View in EDS

miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro.

Saved in:
Bibliographic Details
Title: miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro.
Authors: Kordaß T; GMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany., Weber CEM; GMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany., Eisel D; GMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany., Pane AA; GMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany., Osen W; GMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany., Eichmüller SB; GMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Source: Oncotarget [Oncotarget] 2018 Aug 21; Vol. 9 (65), pp. 32507-32522. Date of Electronic Publication: 2018 Aug 21 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.25986